CompaniesMAC Clinical Research
MAC Clinical Research logo

MAC Clinical Research

active
Blackpool, UK
Founded 2002
Website
About

Clinical Development

Areas of Focus

Categories

Clinical ResearchClinical ResearchClinical ResearchCg RegulatoryClinical Research
Team (16)
Chris Chadwick
Vice President of Healthcare Services
MAC Clinical Research
executive
Claire Horsgood
Vice President of Operations and Growth
MAC Clinical Research
executive
Dr Aliya Asher
Chief Medical Officer
MAC Clinical Research
executive
Dr John Connell
Chief Scientific Officer
MAC Clinical Research
executive
Dr Mark Dale
Chief Executive Officer
MAC Clinical Research
executive
Dr Shoona A Vincent
Vice President of Clinical Science
MAC Clinical Research
executive
View all 16 team members →
Clinical Trials (6)
View all

Total Trials

6

As Lead Sponsor

0

As Collaborator

6

Total Enrollment

443

By Phase

PHASE2: 1PHASE1/PHASE2: 2NA: 1PHASE1: 2

By Status

COMPLETED: 4NOT_YET_RECRUITING: 1RECRUITING: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
NCT03227796
NCT05029401
NCT06648096
NCT06623162
Hover over trial bars to see details

Recent Trials

NCT06623162Collaborator
Sasanlimab As Maintenance Treatment Based on Clinical Response to Neoadjuvant Treatment in Molecularly Categorized Muscle Invasive Bladder Cancer Patients
PHASE2Not yet recruiting
70 participants
Started: Dec 31, 2024 · Completed: Dec 31, 2027
NCT06648096Collaborator
Afatinib in Patients with Fanconi Anemia (FA) and Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)
PHASE1/PHASE2Recruiting
25 participants
Started: Nov 8, 2024 · Completed: Dec 31, 2028
NCT05029401Collaborator
A Study of Oral Ibogaine in Opioid Withdrawal
PHASE1/PHASE2Completed
116 participants
Started: Apr 1, 2021 · Completed: Jan 16, 2024
NCT03920085Collaborator
Clinical Evaluation of LifeScan Blood Glucose Monitoring Systems
NACompleted
123 participants
Started: Jan 8, 2019 · Completed: Feb 5, 2019
NCT03227796Collaborator
Safety, Tolerability & Pharmacokinetics of LEVI-04 in Healthy Volunteers and Patients With Osteoarthritis Knee Pain
PHASE1Completed
56 participants
Started: Jul 28, 2017 · Completed: Mar 31, 2021
View all 6 trials →
Locations (1)
Headquarters
Blackpool, UK
Map

Loading map...